Cypress Pointe Surgical Hospital in Louisiana and myBenefits.ai offer DischargePlus™ for post Care Surgeries

2 months ago

SAN FRANCISCO--(BUSINESS WIRE)--Priyam Parikh, the CEO of myBenefits.ai, has expressed his sincere gratitude to Scott Boudreaux, the Chief Operating Officer,…

Patent Granted to MindMics, Inc. for Groundbreaking Cardiovascular Monitoring via Infrasound Technology in Everyday Headphones

2 months ago

CAMBRIDGE, MA / ACCESSWIRE / January 29, 2024 / MindMics, Inc., a leader in health technology innovation, is proud to…

Protagonist Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2024

2 months ago

NEWARK, CA / ACCESSWIRE / January 29, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh…

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

2 months ago

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st.ORLANDO, FL / ACCESSWIRE / January…

Skye Bioscience Announces $50.25 Million Private Placement Equity Financing

2 months ago

Financing co-led by a leading life science investor and 5AM Ventures expected to fully fund obesity Phase 2 trial assessing…

PMD Announces New ISIN Code and Timetable for Reverse Split of Shares

2 months ago

STOCKHOLM, SWEDEN / ACCESSWIRE / January 29, 2024 / PMD Device Solutions (STO:PROMO)(FRA:8T0) In connection with the reverse share split,…

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

2 months ago

PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea…

4DMT to Host Corporate Webcast to Discuss Interim Data from Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 in Wet AMD Patients with Severe Disease Activity & High Treatment Burden

2 months ago

Initial interim landmark data analysis (N=50 at 24 Weeks) will be presented by Arshad M. Khanani, M.D., M.A., FASRS, Principal…

Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer

2 months ago

REDWOOD CITY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to…